Wong C, Ganz P, Miller L, Kobashigawa J, Schwarzkopf A, Valantine von Kaeper H, Wilensky R, Ventura H, Yeung A C
Stanford University School of Medicine, Stanford, California, USA.
J Heart Lung Transplant. 2001 Apr;20(4):385-92. doi: 10.1016/s1053-2498(00)00230-8.
Luminal narrowing in transplant coronary artery disease is thought to be primarily caused by intimal proliferation, and the role of vascular remodeling is less certain.
We studied cardiac allografts from 83 prospectively recruited patients immediately and 1 year after transplant using intravascular ultrasound in a multicenter study. We measured coronary artery dimensions in 310 angiographically matched segments (175 were also fully matched by ultrasound criteria). At 1 year, lumen area changed by -1.8 +/- 3.7 mm(2) (p < 0.0001, 14% of baseline lumen area). Thirty-three percent of this luminal loss was due to intimal thickening and 67% to vessel shrinkage. Shrinkage also occurred (-0.9 +/- 3.2 mm(2), 7% of baseline total area) in segments free of detectable intimal disease at baseline and at 1 year. Using the mean baseline total vessel area (13.9 mm(2)) as the cutoff, we divided the cohort into the large and the small coronary-segment groups. The large-segment group (n = 176) shrank more (-2.6 +/- 4.4 vs. -0.03 +/- 2.8 mm(2), p < 0.0001), but intimal growth was similar in both groups (0.8 +/- 2.2 vs. 0.4 +/- 1.3 mm(2), p = not significant). Analysis of the 175 fully ultrasound matched sub-cohort showed similar results. Changes in intimal area, total vessel area, and lumen area were similar in segments with (n = 132) and segments without (n = 178) pre-existing donor disease. Despite overall shrinkage, change in total vessel area positively correlated with change in intimal area (r = 0.29, p < 0.0001).
In large coronary segments, coronary artery shrinkage plays an important role in the loss of luminal diameter early after cardiac transplantation, whereas new intimal growth occurs in both large and small segments. Pre-existent donor disease does not aggravate these processes. Compensatory remodeling with increasing intimal growth retards the rate of lumen loss. As is intimal thickening, shrinkage and compensatory remodeling are important pathogenic mechanisms in transplant coronary artery disease.
移植冠状动脉疾病中的管腔狭窄被认为主要由内膜增生引起,而血管重塑的作用尚不确定。
在一项多中心研究中,我们对83例前瞻性招募患者的心脏同种异体移植物在移植后即刻和1年时使用血管内超声进行了研究。我们在310个血管造影匹配节段(其中175个也符合超声标准的完全匹配节段)中测量了冠状动脉尺寸。1年时,管腔面积变化为-1.8±3.7mm²(p<0.0001,为基线管腔面积的14%)。这种管腔损失的33%归因于内膜增厚,67%归因于血管收缩。在基线和1年时无可检测内膜疾病的节段也出现了收缩(-0.9±3.2mm²,为基线总面积的7%)。以平均基线总血管面积(13.9mm²)为界值,我们将队列分为大冠状动脉节段组和小冠状动脉节段组。大节段组(n = 176)收缩更明显(-2.6±4.4 vs. -0.03±2.8mm²,p<0.0001),但两组内膜生长相似(0.8±2.2 vs. 0.4±1.3mm²,p无显著性差异)。对175个完全超声匹配的亚队列分析显示了相似结果。有(n = 132)和无(n = 178)供体原有疾病的节段内膜面积、总血管面积和管腔面积变化相似。尽管总体上血管收缩,但总血管面积变化与内膜面积变化呈正相关(r = 0.29,p<0.0001)。
在大冠状动脉节段中,冠状动脉收缩在心脏移植后早期管腔直径损失中起重要作用,而大小节段均出现新的内膜生长。供体原有疾病不会加重这些过程。内膜生长增加的代偿性重塑减缓了管腔损失速率。与内膜增厚一样,收缩和代偿性重塑是移植冠状动脉疾病的重要致病机制。